CX 717 is a pharmaceutical compound that belongs to a class of drugs known as ampakines, which are designed to enhance cognitive function by modulating the activity of AMPA receptors in the brain. It is primarily investigated for its potential neuroprotective and cognitive-enhancing effects, particularly in conditions such as cognitive impairment and neurodegenerative diseases. CX 717 has been shown to improve memory and learning in preclinical studies, making it a candidate for further research in the treatment of disorders like Alzheimer's disease. The compound is characterized by its ability to increase synaptic transmission and promote neuroplasticity, which are crucial for cognitive processes. Additionally, CX 717 has been studied for its potential effects on attention and alertness, suggesting a broader application in enhancing cognitive performance. However, as with many experimental drugs, the safety, efficacy, and long-term effects of CX 717 require thorough investigation through clinical trials before it can be considered for widespread therapeutic use.

CX 717 (pharmaceutical)

867276-98-0: CX 717 is a pharmaceutical compound that belongs to a class of drugs known as ampakines, which are designed to enhance cognitive function by modulating the activity of AMPA receptors in the brain. It is primarily investigated for its potential neuroprotective and cognitive-enhancing effects, particularly in conditions such as cognitive impairment and neurodegenerative diseases. CX 717 has been shown to improve memory and learning in preclinical studies, making it a candidate for further research in the treatment of disorders like Alzheimer's disease. The compound is characterized by its ability to increase synaptic transmission and promote neuroplasticity, which are crucial for cognitive processes. Additionally, CX 717 has been studied for its potential effects on attention and alertness, suggesting a broader application in enhancing cognitive performance. However, as with many experimental drugs, the safety, efficacy, and long-term effects of CX 717 require thorough investigation through clinical trials before it can be considered for widespread therapeutic use.

CX717

<p>CX 717 is a positive allosteric modulator of AMPA receptor which has an antidepressant-like effect.</p>

CAS 867276-98-0

CX 717 (pharmaceutical)

CX717

Ref: 54-BUP11265

CX717

Ref: TM-T60201